These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 719119)

  • 21. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case study: development of a bioassay for IL-1ra.
    Wolf J
    Dev Biol (Basel); 2002; 107():63-7. PubMed ID: 12079193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fitting bioassay data and performing uncertainty analysis with BIOKMOD.
    Sanchez G
    Health Phys; 2007 Jan; 92(1):64-72. PubMed ID: 17164601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioassay of vitamin A in liquid supplements.
    Newton GL; Tucker RE; Mitchell GE; Schelling GT; Alderson NE; Knight WM
    Int J Vitam Nutr Res; 1979; 49(3):240-5. PubMed ID: 528152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal design of the chronic animal bioassay.
    Portier C; Hoel D
    J Toxicol Environ Health; 1983 Jul; 12(1):1-19. PubMed ID: 6631999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equivalence testing for parallelism in the four-parameter logistic model.
    Jonkman JN; Sidik K
    J Biopharm Stat; 2009 Sep; 19(5):818-37. PubMed ID: 20183446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the performance of logistic regression model types on growth/no growth data of Listeria monocytogenes.
    Gysemans KP; Bernaerts K; Vermeulen A; Geeraerd AH; Debevere J; Devlieghere F; Van Impe JF
    Int J Food Microbiol; 2007 Mar; 114(3):316-31. PubMed ID: 17239980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Park C; Papiez L; Zhang S; Story M; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of some random-barrier, continuous-time random-walk, and other models for the analysis of wide-range frequency response of ion-conducting materials.
    Macdonald JR
    J Phys Chem B; 2009 Jul; 113(27):9175-82. PubMed ID: 19526997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivariate bioassay, combination of bioassays, and Fieller's theorem.
    Srivastava MS
    Biometrics; 1986 Mar; 42(1):131-41. PubMed ID: 3719050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multivariate twin crossover design parallel line assay for estimating potency of insulin].
    Lin ZG; Zhou HJ
    Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):565-8. PubMed ID: 2701785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited utility of the phenylephrine-nitroprusside sigmoid curve method of measuring baroreflex function after myocardial infarction.
    Leitch JW; Newling R; Nyman E; Cox K; Dear K
    J Cardiovasc Risk; 1997 Jun; 4(3):179-84. PubMed ID: 9475672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A distributed lag approach to fitting non-linear dose-response models in particulate matter air pollution time series investigations.
    Roberts S; Martin MA
    Environ Res; 2007 Jun; 104(2):193-200. PubMed ID: 17362914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bayesian analysis of the slope ratio bioassay.
    Mendoza M
    Biometrics; 1990 Dec; 46(4):1059-69. PubMed ID: 2085625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioassay design and MTD setting: old methods and new approaches.
    Swenberg JA
    Regul Toxicol Pharmacol; 1995 Feb; 21(1):44-51; discussion 81-6. PubMed ID: 7784635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response models for developmental malformations.
    Gaylor DW; Chen JJ
    Teratology; 1993 Apr; 47(4):291-7. PubMed ID: 8322223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioassay case study applying the maximin D-optimal design algorithm to the four-parameter logistic model.
    Coffey T
    Pharm Stat; 2015; 14(5):427-32. PubMed ID: 26235135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the methacholine dose-response curve: usefulness of a simplified log-logistic model in epidemiological studies.
    Neukirch F; Maccario J; Korobaeff M; Annesi I; Liard R; Orvoen-Frija E; Kauffmann F
    Bull Eur Physiopathol Respir; 1987; 23(4):383-6. PubMed ID: 3318966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.